Enhancing clinical trial diversity
Stakeholder perspectives on advancing research through representative clinical trials
Racial and ethnic diversity among clinical trial participants is important to support science-driven strategies aimed at understanding the needs of those who are affected by the disease or condition being investigated. How can the biopharma industry achieve this? The answer lies in multistakeholder partnerships.
The Deloitte Health Equity Institutes
Advancing health equity by translating our purpose into action
The Deloitte Health Equity Institutes were established to share our most impactful learnings, extend the efforts of others, and meaningfully contribute to broader health equity issues.
FT Global Pharmaceutical & Biotechnology Conference
2021 global life sciences outlook
Possibility is now reality, sustaining forward momentum
Navigating the pandemic has been an all-encompassing, once-in-a-lifetime challenge. Globally, life sciences companies responded with leadership and are emerging stronger. How will life sciences companies continue to respond and what areas can they build resiliency going forward?